Coronary artery stenosis, resulting in impaired cardiac perfusion, ischemia, and the risk of myocardial infarction,is a major cause of morbidity and mortality in the U. S. population. There is currently tremendous interest inunderstanding the endogenous responses to ischemia and infarction. These studies may lead to thedevelopment of novel therapeutic strategies that protect the heart by promoting adaptive responses or bypreventing maladaptive responses. Ischemia is characterized by deprivation of oxygen (hypoxia), metabolicsubstrates, and cytokines/survival factors, as well as accumulation of toxic metabolites. Despite the complexpathophysiology of ischemia, hypoxia alone is a sufficient stimulus to induce a variety of adaptive responsesthat protect against ischemia-reperfusion injury. An important mediator of these responses is hypoxia-induciblefactor 1 (HIF-1), a transcription factor that regulates the expression of hundreds of genes in response tochanges in cellular oxygenation. Among the known HIF-1 target genes are those encoding erythropoietin(EPO) and vascular endothelial growth factor (VEGF), which promote oxygen delivery to tissues by stimulatingthe production of red blood cells and blood vessels, respectively. HIF-1 target genes also encode survivalfactors, such as insulin-like growth factor 2 as well as EPO and VEGF, which can block apoptotic signalinginduced by ischemia. HIF-1 also controls the expression of glucose transporters and glycolytic enzymes, whichare required for anaerobic ATP production. In this proposal, we will investigate the role of HIF-1 and of proteinsencoded by HIF-1 target genes, such as EPO, in promoting protection against cardiac ischemia-reperfusioninjury.
Aim 1 will investigate the mechanisms by which EPO protects the heart from injury following ischemiaand reperfusion.
Aim 2 will investigate the role of HIF-1 in mediating adaptive responses to cardiac ischemiaand reperfusion.
Aim 3 will investigate the mechanisms and consequences of the recruitment of bone marrowderivedstromal cells to the ischemic heart,
|Velayutham, Murugesan; Hemann, Craig F; Cardounel, Arturo J et al. (2016) Sulfite Oxidase Activity of Cytochrome c: Role of Hydrogen Peroxide. Biochem Biophys Rep 5:96-104|
|Xie, Lin; Talukder, M A Hassan; Sun, Jian et al. (2015) Liposomal tetrahydrobiopterin preserves eNOS coupling in the post-ischemic heart conferring in vivo cardioprotection. J Mol Cell Cardiol 86:14-22|
|Long 3rd, Victor P; Bonilla, Ingrid M; Vargas-Pinto, Pedro et al. (2015) Heart failure duration progressively modulates the arrhythmia substrate through structural and electrical remodeling. Life Sci 123:61-71|
|Reyes, Levy A; Boslett, James; Varadharaj, Saradhadevi et al. (2015) Depletion of NADP(H) due to CD38 activation triggers endothelial dysfunction in the postischemic heart. Proc Natl Acad Sci U S A 112:11648-53|
|Joddar, Binata; Firstenberg, Michael S; Reen, Rashmeet K et al. (2015) Arterial levels of oxygen stimulate intimal hyperplasia in human saphenous veins via a ROS-dependent mechanism. PLoS One 10:e0120301|
|Zheng, Xiaoxu; Zu, Lingyun; Becker, Lewis et al. (2014) Ischemic preconditioning inhibits mitochondrial permeability transition pore opening through the PTEN/PDE4 signaling pathway. Cardiology 129:163-73|
|Moldovan, Nicanor I; Anghelina, Mirela; Varadharaj, Saradhadevi et al. (2014) Reoxygenation-derived toxic reactive oxygen/nitrogen species modulate the contribution of bone marrow progenitor cells to remodeling after myocardial infarction. J Am Heart Assoc 3:e000471|
|Huang, Jie; Huffman, Jennifer E; Yamakuchi, Munekazu et al. (2014) Genome-wide association study for circulating tissue plasminogen activator levels and functional follow-up implicates endothelial STXBP5 and STX2. Arterioscler Thromb Vasc Biol 34:1093-101|
|Chen, Yeong-Renn; Zweier, Jay L (2014) Cardiac mitochondria and reactive oxygen species generation. Circ Res 114:524-37|
|Tong, Jianjing; Zweier, Joseph R; Huskey, Rachael L et al. (2014) Effect of temperature, pH and heme ligands on the reduction of Cygb(Fe(3+)) by ascorbate. Arch Biochem Biophys 554:1-5|
Showing the most recent 10 out of 200 publications